Literature DB >> 8223809

Magnetic resonance imaging in juvenile Canavan disease.

P B Toft1, R Geiss-Holtorff, M O Rolland, O Pryds, W Müller-Forell, E Christensen, W Lehnert, H C Lou, D Ott, J Hennig.   

Abstract

We present a 2-year-old boy and a 6-year-old girl with mild Canavan disease (CD). Aspartoacylase activity in skin fibroblasts was deficient. Magnetic resonance imaging (MRI) of the brain did not show the prominent leucodystrophy previously reported in CD, but there was a hyperintense signal from the lentiform nuclei and the heads of the caudate nuclei on the T2-weighted MR images. This suggests a specific vulnerability of the corpus striatum in these patients. In the older patient, the white matter became affected at the age of 6 years. Proton magnetic resonance spectroscopy (1H-MRS) of white matter revealed a normal concentration of N-acetyl-L-aspartate (NAA) and a markedly decreased concentration of choline containing compounds (Cho) in the boy but a normal ratio of NAA to Cho in the girl. We conclude that deficient NAA catabolism affects myelin metabolism. This may present as changes in the striatum and/or as a low concentration of Cho before leucodystrophy appears on MRI.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8223809     DOI: 10.1007/bf01953994

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  14 in total

1.  N-acetylaspartic aciduria due to aspartoacylase deficiency--a new aetiology of childhood leukodystrophy.

Authors:  L Hagenfeldt; I Bollgren; N Venizelos
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

2.  Aspartoacylase deficiency and N-acetylaspartic aciduria in patients with Canavan disease.

Authors:  R Matalon; K Michals; D Sebesta; M Deanching; P Gashkoff; J Casanova
Journal:  Am J Med Genet       Date:  1988-02

3.  Age-dependent changes in localized proton and phosphorus MR spectroscopy of the brain.

Authors:  M S van der Knaap; J van der Grond; P C van Rijen; J A Faber; J Valk; K Willemse
Journal:  Radiology       Date:  1990-08       Impact factor: 11.105

4.  N-acetylaspartic aciduria in a child with a progressive cerebral atrophy.

Authors:  E A Kvittingen; G Guldal; S Børsting; I O Skalpe; O Stokke; E Jellum
Journal:  Clin Chim Acta       Date:  1986-08-15       Impact factor: 3.786

5.  SSIEM Award. Aspartoacylase deficiency: the enzyme defect in Canavan disease.

Authors:  R Matalon; R Kaul; J Casanova; K Michals; A Johnson; I Rapin; P Gashkoff; M Deanching
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

6.  Localized 1H NMR spectroscopy in Canavan's disease: a report of two cases.

Authors:  S J Austin; A Connelly; D G Gadian; J S Benton; E M Brett
Journal:  Magn Reson Med       Date:  1991-06       Impact factor: 4.668

Review 7.  A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline.

Authors:  B L Miller
Journal:  NMR Biomed       Date:  1991-04       Impact factor: 4.044

8.  Urinary excretion of succinylacetone and delta-aminolevulinic acid in patients with hereditary tyrosinemia.

Authors:  E Christensen; B B Jacobsen; N Gregersen; H Hjeds; J B Pedersen; N J Brandt; U B Baekmark
Journal:  Clin Chim Acta       Date:  1981-11-11       Impact factor: 3.786

9.  Use of computed tomography, magnetic resonance imaging, and localized 1H magnetic resonance spectroscopy in Canavan's disease: a case report.

Authors:  H G Marks; P A Caro; Z Y Wang; J A Detre; A R Bogdan; D A Gusnard; R A Zimmerman
Journal:  Ann Neurol       Date:  1991-07       Impact factor: 10.422

10.  In vivo quantification of brain metabolites by 1H-MRS using water as an internal standard.

Authors:  P Christiansen; O Henriksen; M Stubgaard; P Gideon; H B Larsson
Journal:  Magn Reson Imaging       Date:  1993       Impact factor: 2.546

View more
  9 in total

1.  Redirecting N-acetylaspartate metabolism in the central nervous system normalizes myelination and rescues Canavan disease.

Authors:  Dominic J Gessler; Danning Li; Hongxia Xu; Qin Su; Julio Sanmiguel; Serafettin Tuncer; Constance Moore; Jean King; Reuben Matalon; Guangping Gao
Journal:  JCI Insight       Date:  2017-02-09

2.  Molecular characterisation and prenatal diagnosis of Asparto-acylase deficiency (Canavan disease)--report of two novel and two known mutations from the Indian subcontinent.

Authors:  Sunita Bijarnia; Sudha Kohli; Ratna Dua Puri; Rintu J Jacob; Renu Saxena; Anil Jalan; Eric A Sistermans; Saqib Mahmood; Ishwar Chander Verma
Journal:  Indian J Pediatr       Date:  2012-08-10       Impact factor: 1.967

3.  Cribriform Appearance of White Matter in Canavan Disease Associated with Novel Mutations of ASPA Gene.

Authors:  Maya Dattatraya Bhat; Netravathi Manjunath; Renu Kumari; Mohammed Faruq; Pramod Kumar Pal; Chandrajit Prasad; Ravindranadh Chowdary Mundlamuri; Atchayaram Nalini; Gautham Arunachal Udupi; Priyanka Priyadarshini Baishya; Karthik Kulanthaivelu
Journal:  J Pediatr Genet       Date:  2021-03-10

Review 4.  Tools for diagnosis of leukodystrophies and other disorders presenting with white matter disease.

Authors:  Adeline Vanderver
Journal:  Curr Neurol Neurosci Rep       Date:  2005-03       Impact factor: 5.081

5.  The molecular basis of canavan (aspartoacylase deficiency) disease in European non-Jewish patients.

Authors:  A Shaag; Y Anikster; E Christensen; J Z Glustein; A Fois; H Michelakakis; F Nigro; E Pronicka; A Ribes; M T Zabot
Journal:  Am J Hum Genet       Date:  1995-09       Impact factor: 11.025

6.  Atypical clinical and radiological course of a patient with Canavan disease.

Authors:  Catherine Sarret; Odile Boespflug-Tanguy; Diana Rodriguez
Journal:  Metab Brain Dis       Date:  2015-11-19       Impact factor: 3.584

Review 7.  Canavan Disease as a Model for Gene Therapy-Mediated Myelin Repair.

Authors:  Anoushka Lotun; Dominic J Gessler; Guangping Gao
Journal:  Front Cell Neurosci       Date:  2021-04-23       Impact factor: 6.147

8.  The Clinical Features and Diagnosis of Canavan's Disease: A Case Series of Iranian Patients.

Authors:  Parvaneh Karimzadeh; Narjes Jafari; Habibe Nejad Biglari; Elham Rahimian; Farzad Ahmadabadi; Hamid Nemati; Mohamad Mehdi Nasehi; Mohammad Ghofrani; Mohsen Mollamohammadi
Journal:  Iran J Child Neurol       Date:  2014

9.  Clinically Distinct Phenotypes of Canavan Disease Correlate with Residual Aspartoacylase Enzyme Activity.

Authors:  Marisa I Mendes; Desirée Ec Smith; Ana Pop; Pascal Lennertz; Matilde R Fernandez Ojeda; Warsha A Kanhai; Silvy Jm van Dooren; Yair Anikster; Ivo Barić; Caroline Boelen; Jaime Campistol; Lonneke de Boer; Ariana Kariminejad; Hulya Kayserili; Agathe Roubertie; Krijn T Verbruggen; Christine Vianey-Saban; Monique Williams; Gajja S Salomons
Journal:  Hum Mutat       Date:  2017-02-14       Impact factor: 4.878

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.